Dry Eye Explained: Why Drops Don't Fix It — MGD, Meibography & IPL

At Eyecare Center of Orange County, Dr. Alexander Bonakdar has cared for patients for more than three decades. Trained at Bascom Palmer, board certified, and trusted by more than ten thousand Orange County patients since nineteen ninety one.

Dry eye rarely announces itself as dryness. Patients describe burning, a gritty feeling like sand in the eye, vision that blurs and then clears when they blink, and surprisingly, watery eyes. When the oil layer fails, the eye floods itself with reflex tears that run straight off the lid. Contacts that used to be comfortable stop working and symptoms get worse as the day goes on. This is a medical condition, not an inconvenience.

About 8% of American adults carry a dry eye diagnosis, and screening based on clinical signs finds far more. Roughly 21% have meibomian gland dysfunction, and in about 86% of dry eye cases, those oil glands are part of the problem. Left alone, dry eye progresses.

Along the edge of each eyelid sits a row of 25 to 40 tiny oil glands called meibomian glands. Every time you blink, they release a thin film of oil over your tears. That oil layer keeps tears from evaporating, gives you a smooth, clear surface to see through, and forms a barrier against bacteria. It is the top layer of your tear film, and it is the layer that fails first.

Here is why this matters. In about half of dry eye patients, the oil glands are the only cause. In another 36%, gland disease is mixed with reduced tear production. Only about 14% is purely a water shortage. For decades, dry eye was treated as a water problem, with drops and plugs. If your problem is the oil layer, artificial tears wash out in minutes while the gland disease keeps advancing.

Gland failure happens in stages. First, the gland opening thickens and narrows. Then the trapped oil stiffens, and its melting point climbs above body temperature. Pressure backs up, the gland swells, and the oil producing cells begin to die. Finally, the gland shortens, twists and disappears. That last stage does not reverse. We can open blocked glands and protect the ones you still have, but we cannot grow back glands that are gone.

This is what we are looking at. On the left, healthy glands, long, full, tightly packed, reaching most of the way up the eyelid. On the right, advanced gland loss. Notice the wide, empty spaces where glands used to be, and the short stumps that remain. Infrared imaging, called meibography, lets us photograph your glands in about two minutes. It turns an abstract diagnosis into something you can see, and it tells us how much time we have.

Most patients have several drivers at once. Screens are a big one. Your blink rate falls from roughly 15 to 20 times a minute down to about 5 to 7. And many of those blinks are incomplete, so the glands never get squeezed. Age and hormones matter, especially around menopause. So do common medications. Dry air, contact lens wear, prior LASIK, and Demodex mites at the base of the lashes.

The current international standard, published in 2025, requires both symptoms and a measurable sign before we diagnose dry eye disease. So we ask you a short six question survey. We time how many seconds your tear film lasts before it breaks up, and measure how salty your tears are, and we look at the surface with dye while photographing the glands themselves.

This is why a warm washcloth often is not enough. Healthy oil melts at about body temperature. Once glands are blocked, the oil stiffens, and the gland itself has to reach 104 to 106 degrees to clear. Skin only safely tolerates about 110. Only a fraction of surface heat reaches the glands through the lid, and a washcloth loses most of its heat in a couple of minutes. In advanced disease, the melting point can exceed 113 degrees.

Home care is still the foundation, and none of it is optional. Artificial tears four times a day, switching to preservative free vials if you need them more often. A gel or ointment at bedtime. Sustained heat for eight to ten minutes, followed by gentle massage toward the lash line. Daily lid hygiene. Deliberate complete blinks every twenty minutes on screens. And changing the air around you.

In the office we can do things a compress cannot. We clear the lid margin first because blocked openings have to be opened before heat or light can help. Thermal pulsation devices heat the inner lid surface directly and express the glands. Intense pulsed light targets the inflammation feeding the disease, and punctal plugs slow tear drainage when low tear volume is genuinely part of the picture.

Intense pulsed light, or IPL, comes from dermatology, where it has treated rosacea for decades. In April of 2021, the FDA authorized the first IPL device, specifically for improving the signs of dry eye disease caused by meibomian gland dysfunction.

Here is why it works. Gland disease is a loop. Abnormal leaky blood vessels along the lid margin deliver inflammatory chemicals straight to the glands. Those chemicals damage the gland cells. So the oil thickens and the glands clog. The tear film destabilizes, the surface becomes stressed and inflamed, and that inflammation drives even more abnormal vessel growth. Drops treat the symptoms of this loop. IPL goes after the vessels that feed it, which is why it can change the direction of the disease, rather than just managing it.

In practice, IPL does five things. The light is absorbed by hemoglobin, so the abnormal vessels collapse. It reduces Demodex mites and bacteria at the lash line. It warms and thins the trapped oil, so the glands can actually be expressed. It lowers inflammatory markers in the tears, and it appears to help gland tissue and lid tone recover.

A standard course is four sessions, on day one, day fourteen, day twenty eight, and day forty nine, followed by maintenance every six to twelve months. Each visit takes about fifteen minutes. You wear protective shields, we apply a cooling gel, and you feel a warm snap like a light rubber band. Then we express the glands while the oil is still soft, which is where much of the benefit comes from.

We would rather set the right expectation than oversell a procedure. Across eleven randomized trials and seven hundred fifty nine patients, tear film stability improved consistently, and meibum quality and gland expressibility improved in the trials supporting FDA authorization. Safety is good. But symptom improvement varies between studies. The benefit fades over about nine months, which is why maintenance exists, and IPL works best as part of a combined plan, not on its own.

Prescription options have changed dramatically. Miebo is the first drop aimed directly at evaporation. Xdemvy kills Demodex mites. Tryptyr, approved in 2025, stimulates your own eye to make tears. Tyrvaya is a nasal spray that does something similar, and cyclosporine remains the backbone of long term anti inflammatory therapy, often bridged with a short steroid course.

If any of this sounded like you, please say something before you leave today. Ask us to look at your glands. Ask whether you are a candidate for IPL. Ask what you should be doing at home. Most of what we can do works best before glands are lost.